FDA releases new guidance on 3D printed medical products

Add bookmark

The industry witnessed a world-first last week, as the US Food and Drug Administration  released guidance for manufacturers 3D printing medical products

This year’s news of the first 3D printed drug receiving FDA approval illustrated the surprising speed of life-changing technologies in today’s market.

The FDA is working to keep pace with these advances and provide a ‘comprehensive regulatory pathway’ to facilitate access to safe and effective innovations.

FDA guidance

The document signals the FDA’s positioning and initial thoughts on the technology.  However, the views are likely to evolve as it builds a regulatory framework incorporating 3D printed personalised devices for patients.

Industry response

Many in the industry applauded the FDA for its forward thinking, commitment and appreciation for the technology, noting that the guidance does indeed provide a clearer path for the industry.

FDA methodology

The body reviewed over 100 devices produced by 3D printers. These products are custom tailored to a patient’s requirements such as implants to fit unique openings in skull or facial reconstructions.

The authority also envisions that one day entire replacement organs will be 3D printed and burn patients will have their new skin cells 3D printed directly onto burn wounds.

The guidance covers a range of areas including: patient-matched device design, software workflow, biocompatibility and mechanical testing.

View the guidance in full here: Technical Considerations for Additive Manufactured Medical Devices


Upcoming Events

Cosmetic Compliance New York 2016

October 17 - 19, 2016

MANHATTAN NYC – An Affinia Hotel Collection, New York, NY

Cosmetic Compliance New York 2016

Pharma Traceability November - 2016

November 30 - December 2, 2016

Sheraton Philadelphia University City Hotel, Philadelphia, PA

Pharma Traceability November - 2016

UDIs and Traceability for Medical Devices

15 - 18 May, 2018

Pullman Brussels Centre Midi Hotel, Brussels, Belgium

UDIs and Traceability for Medical Devices

CRISPR: A New Era in Gene Editing

December 5 - 7, 2016

Embassy Suites by Hilton Boston at Logan Airport, Boston, MA

CRISPR: A New Era in Gene Editing

10. Jahreskonferenz Pharma Packaging 2016

29 February - 2 March, 2016

Golden Tulip Berlin - Hotel Hamburg, Berlin, Germany

10. Jahreskonferenz Pharma Packaging 2016

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...